Your session is about to expire
← Back to Search
Device
Streamline Surgical System vs iStent for Open-Angle Glaucoma (VENICE Trial)
N/A
Recruiting
Research Sponsored by New World Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of Mild to Moderate Primary Open Angle Glaucomma
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
VENICE Trial Summary
This trial compared the Streamline Surgical System to a competitor for use in surgeries.
Who is the study for?
This trial is for people with mild to moderate Primary Open-Angle Glaucoma. It's not open to those with other glaucoma types like normal tension, pseudoexfoliative, narrow angle, traumatic, congenital, malignant, uveitic or neovascular glaucoma or just ocular hypertension.Check my eligibility
What is being tested?
The study compares two treatments for Open-Angle Glaucoma: the Streamline Surgical System and iStent Inject W. Patients will receive one of these interventions to see which is more effective.See study design
What are the potential side effects?
Potential side effects are not specified in the provided information. Generally, surgical interventions for glaucoma may include risks such as infection, bleeding inside the eye (hyphema), increased eye pressure or vision loss.
VENICE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with mild to moderate open-angle glaucoma.
VENICE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in mean unmedicated diurnal Intraocular Pressure (IOP)
VENICE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Streamline Surgical SystemExperimental Treatment1 Intervention
Streamline Surgical System procedure administered
Group II: iStent Inject WActive Control1 Intervention
iStent Inject W implanted
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Streamline Surgical System
2021
N/A
~50
Find a Location
Who is running the clinical trial?
New World Medical, Inc.Lead Sponsor
7 Previous Clinical Trials
395 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have high eye pressure.I have a specific type of glaucoma, not the most common one.I have been diagnosed with mild to moderate open-angle glaucoma.
Research Study Groups:
This trial has the following groups:- Group 1: Streamline Surgical System
- Group 2: iStent Inject W
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there vacancies available for participants in this investigation?
"Affirmative. According to information hosted on clinicaltrials.gov, the trial which was initiated on February 9th 2022 and last revised March 14th 2022 is searching for participants. 150 patients must be enrolled from a single location."
Answered by AI
How many participants are being monitored in this research endeavor?
"Affirmative. The information extant on clinicaltrials.gov corroborates that this medical experiment is actively recruiting volunteers; it was initially posted in February of 2022 and most recently updated in March of the same year, with a need for 150 participants at one site."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger